---
layout: page
title: Publications
permalink: /pubs/
---
General
<div>
Gillies, R. J., Kinahan, P. E. & Hricak, H. Radiomics: Images Are More than Pictures, They Are Data. Radiology 278, 563–577 (2016).
Aerts, H. J. W. L. et al. Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat. Commun. 5, 4006 (2014).
Parmar, C., Grossmann, P., Bussink, J., Lambin, P. & Aerts, H. J. W. L. Machine Learning methods for Quantitative Radiomic Biomarkers. Sci. Rep. 5, 13087 (2015).
Leger, S. et al. A comparative study of machine learning methods for time-To-event survival data for radiomics risk modelling. Sci. Rep. 7, (2017).
<div>
Lung
<div>
Head & Neck
<div>
Glioma
<div>
Kickingereder, P. et al. Large-scale radiomic profiling of recurrent glioblastoma identifies an imaging predictor for stratifying anti-angiogenic treatment response. Clin. Cancer Res. 22, 5765–5771 (2016).
Zhang, B. et al. Multimodal MRI features predict isocitrate dehydrogenase genotype in high-grade gliomas. Neuro. Oncol. 19, 109–117 (2017).
Macyszyn, L. et al. Imaging patterns predict patient survival and molecular subtype in glioblastoma via machine learning techniques. Neuro. Oncol. 18, 417–425 (2016).
Chang, K. et al. Multimodal imaging patterns predict survival in recurrent glioblastoma patients treated with bevacizumab. Neuro. Oncol. 18, 1680–1687 (2016).
Gevaert, O. et al. Glioblastoma Multiforme: Exploratory Radiogenomic Analysis by Using Quantitative Image Features. Radiology 273, 168–174 (2014).
Grossmann, P. et al. Quantitative Imaging Biomarkers for Risk Stratification of Patients with Recurrent Glioblastoma Treated with Bevacizumab. Neuro. Oncol. 1–32 (2017). doi:10.1093/neuonc/nox092
Kickingereder, P. et al. Radiomic Profiling of Glioblastoma: Identifying an Imaging Predictor of Patient Survival with Improved Performance over Established Clinical and Radiologic Risk Models. Radiology 280, 880–889 (2016).
Rathore, S. et al. Radiomic MRI signature reveals three distinct subtypes of glioblastoma with different clinical and molecular characteristics, offering prognostic value beyond IDH1. Sci. Rep. 8, 5087 (2018).
Beig, N. et al. Radiogenomic analysis of hypoxia pathway is predictive of overall survival in Glioblastoma. Sci. Rep. 8, (2018).
Xi, Y. Bin et al. Radiomics signature: A potential biomarker for the prediction of MGMT promoter methylation in glioblastoma. Journal of Magnetic Resonance Imaging (2017). doi:10.1002/jmri.25860
Li, Z., Wang, Y., Yu, J., Guo, Y. & Cao, W. Deep Learning based Radiomics (DLR) and its usage in noninvasive IDH1 prediction for low grade glioma. Sci. Rep. 7, (2017).
